betameprodine

Betameprodine is a synthetic opioid analgesic and a structural analogue of meperidine. It is classified as a Schedule I controlled substance by the United States Drug Enforcement Administration, indicating it has no currently accepted medical use in the US and a high potential for abuse. Betameprodine acts as an agonist at the mu-opioid receptor, producing typical opioid effects such as analgesia, euphoria, sedation, itching, nausea, and respiratory depression. Its stereoisomer alphameprodine was more widely used historically; both are sometimes collectively referred to as meprodine. The drug is under international control according to the UN Single Convention of 1961[1][2][3][5].

Other names

BetameprodinaBetameprodinumbeta-meprodine